Study of the Mechanism of TCR Antagonism Using Dual-TCR-Expressing T Cells (Q40653232)

22 September 2017

title

Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells (English)

1 reference

22 September 2017

Study of the Mechanism of TCR Antagonism Using Dual-TCR-Expressing T Cells (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

26 December 2023

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

26 December 2023

author name string

Wen Yang

1

1 reference

22 September 2017

Howard M. Grey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12707330

26 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

22 September 2017

published in

Journal of Immunology

1 reference

22 September 2017

volume

170

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

4532-4538

1 reference

T cell receptor antagonist peptides induce positive selection

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Evidence for a differential avidity model of T cell selection in the thymus

26 December 2023

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists

26 December 2023

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Selection of the T cell repertoire.

26 December 2023

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

T-cell-receptor affinity and thymocyte positive selection

26 December 2023

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

26 December 2023

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

26 December 2023

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

26 December 2023

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope

26 December 2023

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

26 December 2023

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

26 December 2023

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Antigen analogs/MHC complexes as specific T cell receptor antagonists

26 December 2023

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs

26 December 2023

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

An unusual mechanism for ligand antagonism

26 December 2023

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Cross-antagonism of a T cell clone expressing two distinct T cell receptors

26 December 2023

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Peptide antagonism and T cell receptor interactions with peptide-MHC complexes

26 December 2023

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Correlations between T-cell specificity and the structure of the antigen receptor

26 December 2023

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

26 December 2023

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope

26 December 2023

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant

26 December 2023

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas

26 December 2023

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists

26 December 2023

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism

26 December 2023

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

26 December 2023

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Ligands for the T-cell receptor: hard times for avidity models

26 December 2023

31

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Three-dimensional segregation of supramolecular activation clusters in T cells

26 December 2023

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers

26 December 2023

33

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor

26 December 2023

34

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]

26 December 2023

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation

26 December 2023

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness

26 December 2023

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events

26 December 2023

39

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.170.9.4532

26 December 2023

Identifiers

1 reference

22 September 2017

1 reference